Table 3.
Indication of hysterectomy in relation to the approach.
| Indications | Abdominal | Vaginal | Laparoscopic | ||||||
|---|---|---|---|---|---|---|---|---|---|
| TAH | TAH + USO | TAH + BSO | Staging laparotomy |
Radical hysterectomy |
VH + PFR | NDVH | LAVH | TLH | |
| Fibroid (210) | 54 (10.2) |
12 (2.3) |
124 (23.5) |
00 | 00 | 02 (0.4) |
05 (0.9) |
12 (2.3) |
01 (0.2) |
| Prolapse (86) | 00 | 00 | 01 (0.2) |
00 | 00 | 83 (15.7) |
00 | 02 (0.4) |
00 |
| DUB (43) | 08 (1.5) |
00 | 26 (4.9) |
00 | 00 | 00 | 03 (0.6) |
06 (1.1) |
00 |
| Adenomyosis (21) | 01 (0.2) |
01 (0.2) |
15 (2.9) |
00 | 00 | 00 | 01 (0.2) |
03 (0.6) |
0 0 |
| Endometriosis (07) | 00 | 01 (0.2) |
06 (1.1) |
00 | 00 | 00 | 00 | 00 | 00 |
| Ovarian tumor benign (42) | 00 | 04 (0.8) |
35 (6.6) |
00 | 00 | 00 | 00 | 02 (0.2) |
00 |
| Ovarian tumor malignant (47) | 00 | 00 | 02 (0.4) |
45 (8.5) |
00 | 00 | 00 | 00 | 00 |
| Endometrial hyperplasia (25) | 01 (0.2) |
00 | 18 (3.4) |
00 | 00 | 00 | 02 (0.4) |
04 (0.8) |
00 |
| Endometrial cancer (20) | 00 | 00 | 00 | 19 (3.6) |
01 (0.2) |
00 | 00 | 00 | 00 |
| CIN (17) | 03 (0.6) |
00 | 09 (1.7) |
00 | 01 (0.2) |
01 (0.2) |
00 | 03 (0.6) |
00 |
| Cervical cancer (04) | 00 | 00 | 00 | 00 | 03 (0.6) |
01 (0.2) |
00 | 00 | 00 |
| Postmenopausal bleeding (16) | 00 | 00 | 13 (2.5) |
00 | 00 | 00 | 00 | 03 (0.6) |
00 |
| Chronic PID (07) | 01 (0.2) |
02 (0.4) |
03 (0.6) |
00 | 00 | 00 | 00 | 01 (0.2) |
00 |
| PPH | 04 (0.7) |
00 | 0 | 00 | 00 | 00 | 00 | 00 | 00 |
| Puerperal sepsis | 00 | 01 (0.2) |
00 | 00 | 00 | 00 | 00 | 00 | 00 |
| Ruptured uterus | 03 (0.6) |
00 | 00 | 00 | 00 | 00 | 00 | 00 | 00 |